Cartography Announces Appointment of Troy Wilson, Ph.D., J.D., to its Board of Directors
Cartography Announces Strategic Collaboration with Gilead to Develop Oncology Therapies Against Novel Targets and Target Pairs
Cartography Biosciences Expands Leadership Team with Appointment of Dan Rock, Ph.D., as Chief Scientific Officer to Advance Novel Oncology Programs into Clinic
— Dr. Rock to support Cartography in the translation of tumor-specific targets into therapeutics, with initial focus on its lead program for colorectal cancer (CRC) — SOUTH SAN FRANCISCO, February 7, 2024 Cartography Biosciences, an oncology company advancing a...